Bitcoin is trading around $79,568 with a narrow price range due to the upcoming expiry of 135,545 Bitcoin options contracts on Deribit this Friday, worth about $10.8 billion. Most call options are set far above the current price, making them likely to expire worthless, which typically leads to a release of capital and potential price movement after expiry. The market's current tight range reflects hedging activity rather than directional bets, and the Federal Reserve meeting midweek adds further uncertainty. Investors should expect more price movement after the expiry and not interpret the current calm as a trend indicator.
Bitcoin at $79,568 is noted here with data as of Oct 27, 2026 12:21 WIB. For readers following major cryptocurrencies on Pluang, the breadth shows 24 out of 50 priced assets rose and 24 fell today. Notable movers include BAL (Balancer) at Rp16.297 with a 1-day change of +11.14%, EOS (EOS.IO) at Rp12.649 with +8.13%, and CAKE (PancakeSwap) at Rp39.022 with a 1-day change of +4.91% and Pluang order activity of 35% Sell / 65% Buy. The most notable figure is BAL's +11.14% gain.
Roche has received the CE Mark for its new cobas smart e immunoanalyser, a compact device designed to deliver central-lab quality testing in smaller healthcare settings. With over 100 planned assays and rapid reaction times under 18 minutes for most ...
Ethereum's price has dropped close to the $2,300 support level after losing about 13.6% in October, pressured by ongoing withdrawals from U.S. spot ETH ETFs and selling by early investors. Key technical indicators remain bearish, with analysts highli...
The WisdomTree US Value Fund, which invests in large and mid-cap stocks with strong shareholder yields, has been upgraded to a "buy" rating. The fund's dividend yield is about 2.04%, and its net buyback yield is 3.45%. While the fund previously showe...
Viridien, a French advanced technology and Earth data company, will publish its Q3 2026 financial results on November 3, 2026, after the market closes. The company will also hold an English-language conference call at 6:00 pm CET the same day to disc...
ONWARD Medical, a neurotechnology company specializing in therapies for spinal cord injury, will release its Q3 2026 financial results on November 3, 2026. The company will also host a webcast featuring CEO Dave Marver to provide a comprehensive busi...
